Katalina M.

Background

About Katalina M.

Passionate About AI & ML in Drug Discovery | Bridging Science, Innovation & Business I have extensive experience in pharmaceutical R&D and have dedicated my career to integrating cutting-edge Artificial Intelligence (AI) and Machine Learning (ML) into drug discovery and development. My expertise spans all stages from early drug design to clinical translation, with a focus on oncology, immunotherapy and precision medicine. AI & ML-Driven Drug Discovery At Pfizer, I lead AI/ML strategies to optimize target identification, molecule design, and high-throughput screening (HTS), accelerating the path from discovery to clinical validation. I am deeply involved in integrating AI with CRISPR gene editing, 3D cell culture, and single-cell omics, pushing the boundaries of innovation in biotech. From Scientific Discovery to Business Impact Beyond R&D, I have a keen understanding of biotech investment, corporate strategy, and translational science. Having worked across Singapore, the US, and global pharma hubs, I collaborate with multidisciplinary teams and strategic partners to bridge the gap between cutting-edge research and real-world medical impact. I am always open to discussing emerging biotech innovations, AI-driven drug discovery, and investment opportunities.